HOME >> MEDICINE >> NEWS
Diet high in vitamin C decreases stroke risk, especially among smokers

ST. PAUL, MN Eating a diet high in vitamin C may decrease your risk of stroke, particularly if you smoke, according to a study published in the November 11 issue of Neurology, the scientific journal of the American Academy of Neurology.

The study found that people with the lowest amount of vitamin C in their diets were 30 percent more likely to have a stroke than people with the highest amount of vitamin C in their diets. Smokers with diets high in vitamin C were more than 70 percent less likely to have a stroke than smokers with diets low in vitamin C.

Antioxidants such as vitamin C may protect cells from oxidative stress, which plays a role in stroke.

Vitamin E was also protective for smokers. Those with diets high in vitamin E were more than 20 percent less likely to have a stroke than those with diets low in vitamin E. No similar advantage was found in non-smokers whose diets were high in vitamin E.

"Of course these study findings do not justify smoking. No one should smoke," said study author Monique Breteler, MD, PhD, of Erasmus Medical Center in Rotterdam. "But it is good news that high levels of antioxidants may help reduce the risk of stroke in smokers."

The study involved 5,197 people age 55 or older in Rotterdam, the Netherlands. All of the participants had no cognitive problems, were living independently and had never had a stroke.

The participants were then tracked for an average of 6.4 years. During that time, 253 people had strokes.

People with the highest amount of vitamin C in their diets consumed greater than 133 mg of vitamin C per day. People with the lowest amount in their diets consumed less than 95 mg per day.

To determine their levels of vitamin C and other antioxidants, participants first indicated on a checklist all foods and drinks they had consumed at least twice a month during the past year. Then they were interviewed by a dietician about their diet.

The use of diet
'"/>

Contact: Marilee Reu
mreu@aan.com
651-695-2789
American Academy of Neurology
10-Nov-2003


Page: 1 2

Related medicine news :

1. Not enough evidence that multivitamins prevent infections in the elderly
2. Folic acid and vitamin B12 decrease risk of hip fracture in stroke patients
3. Calcium and vitamin D most effective for treatment of Crohns-related bone loss
4. High doses of vitamin E supplements do more harm than good
5. Study shows high-dose vitamin E supplements may increase risk of dying
6. Center refutes finding that added sugars displace vitamins and minerals
7. Study showed vitamin D inadequacy highly prevalent among women treated for osteoporosis
8. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
9. International experts discuss latest research on vitamin E & health
10. Red palm oil as a means of combating vitamin A deficiency
11. Low vitamin B12 is associated with poorer memory in older people with high risk for Alzheimers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Diet high vitamin decreases stroke risk especially among smokers

(Date:8/28/2014)... 2014 Kirklyn Smith, an office manager for ... a new world’s record by walking 5,000 miles in a ... constantly amazed by the thousands of individual stories of TrekDesk ... to stand out more than the others. , Kirklyn has ... count which tallies a range of 54,823 steps (presumably on ...
(Date:8/28/2014)... (HealthDay News) -- Lack of sleep not only puts teens ... increased risk for obesity, researchers warn. The study authors ... were aged 16 and 21. Nearly one-fifth of them got ... were age 16, and this group was 20 percent more ... got more than eight hours of sleep per night at ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 NJ ... Institute of North Jersey. , NJ Top Doc, ... is now a certified medical examiner for the ... certified by the department to perform all drug ... training in diagnosing and treating musculoskeletal disorders including ...
(Date:8/28/2014)... In 2012, The Ben & Catherine Ivy Foundation ... brain cancer research projects at the Translational Genomics ... officially received the final regulatory approval from University ... for the trial can begin. , In the ... Trial," TGen and its clinical partners will lead ...
(Date:8/28/2014)... August 28, 2014 As Mirena IUD ... around the U.S., Bernstein Liebhard LLP notes that a ... like Mirena as ideal birth control for teenage girls. ... authors of the study point out that IUDs are ... other methods favored by this patient population. Their study, ...
Breaking Medicine News(10 mins):Health News:There are many reasons why Americans' exercise levels have declined - Meet an executive that refuses to sit still with his TrekDesk Treadmill Desk even in a sedentary job 2Health News:Less Sleep in Teen Years Tied to More Pounds at 21 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 3Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 3Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 4
(Date:8/28/2014)... Aug. 28, 2014  In recognition of the increased ... from the flu, pneumonia, shingles and other illnesses, ... declared September to be Senior Vaccination Month. Because ... is important that adults ages 65 years and ... CVS pharmacists and MinuteClinic nurse practitioners and physician ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire/ ... market research report is available in ... Therapeutics in Asia-Pacific Markets to 2020 ... Unmet Need in Newly Diagnosed and ... http://www.reportlinker.com/p02343492/Glioblastoma-Multiforme-Therapeutics-in-Asia-Pacific-Markets-to-2020---Novel-Therapeutic-Approaches-Target-High-Unmet-Need-in-Newly-Diagnosed-and-Recurrent-GBM.html Glioblastoma ...
(Date:8/28/2014)... , Aug. 28, 2014 Telik, Inc. ... company that merged with MabVax Therapeutics, Inc. on ... significant progress related to the development of its ... was recovered using the Company,s internally developed antibody ... potential for multiple antibody based therapeutic and diagnostic ...
Breaking Medicine Technology:September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
Cached News: